774
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus

, , , , , , , , , , , & show all
Pages 395-400 | Received 25 May 2007, Published online: 08 Jul 2009

References

  • Kitabchi, AE, Fisher, JN, Murphy, MB, Rumbail, MJ. Diabetic Ketoacidosis and the hyperglycemic, hyperosmolar non ketotic state. Chapter 41. In: Kahn CR, Weir GC. Joslin's Diabetes Mellitus. 13th ed. Philadelphia: Lea & Febiger; 1991. p. 738–70.
  • Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, et al. Fulminant Type 1 Diabetes. Diabetes Care. 2003; 26: 2345–52
  • Imagawa A, Hanafusa T, Miyagawa J, Masuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med. 2000; 32: 539–43
  • Brian EW, Schecher AJ, Persons EL. Unusual glycogen storage in a case of diabetes mellitus. Arch Intern Med. 1937; 59: 685–90
  • Vallance-Owen J. Liver glycogen in diabetes mellitus. J Clin Pathol. 1952; 5: 42–53
  • Tomihira M, Kawasaki E, Nakajima H, Imamura Y, Sato Y, Sata M, et al. Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL). Diabetes Res Clin Pract. 2004; 65: 175–82
  • Olsson R, Wesslau C, William-olsson T, Zettergren L. Elevated aminotransferases and alkaline phosphatases in unstable diabetes mellitus without ketoacidosis or hypoglycemia. J Clin Gastroenterol. 1989; 11: 541–5
  • Takaike H, Uchigata Y, Iwasaki N, Iwamoto Y. Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract. 2004; 64: 27–32
  • Imagawa, A, Hanafusa, T, Miyagawa, J, Matsuzawa, Y; the Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000;342:301–7.
  • Weidman SW, Ragland JB, Fischer JN, Jr, Kitabchi AE, Sabesin SM. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment. J Lipid Res. 1982; 23: 171–82
  • Foster DW, McGarry JD. The metabolic derangements and treatment if diabetic ketoacidosis. N Engl J Med. 1983; 309: 159–69
  • Hasty AH, Shimano H, Yahagi N, Amemiya-Kudo M, Perrey S, Yoshikawa T, et al. Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level. J Biol Chem. 2000; 275: 31069–77
  • Shimomura I, Bashmakov Y, Hortons JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem. 1999; 274: 30028–32
  • Bronstein HD, Kantrowitz PA, Schaffner F. Marked enlargement of the liver and transient ascites associated with the treatment of diabetic acidosis. N Engl J Med. 1959; 261: 1314–8
  • Manderson WG, McKiddie MT, Manners DJ, Start JR. Liver glycogen accumulation in unstable diabetes. Diabetes. 1968; 17: 13–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.